Welcome to our dedicated page for Ambiq Micro SEC filings (Ticker: AMBQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ambiq Micro, Inc. (NYSE: AMBQ) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a fabless semiconductor company focused on ultra-low-power edge AI solutions, Ambiq uses these filings to report material events, financial results, governance changes, and equity compensation matters related to its SPOT®-based technology business.
Investors can review Form 8-K current reports in which Ambiq furnishes quarterly earnings press releases, detailing net sales, gross profit, operating expenses, net loss, and non-GAAP measures such as non-GAAP gross profit and non-GAAP net loss. These filings also describe business drivers like product mix, geographic revenue shifts, and demand for Apollo and other edge AI platforms. Additional 8-K items document events such as the completion of Ambiq’s initial public offering on the New York Stock Exchange and subsequent board and executive compensation decisions.
Over time, users can expect this page to include annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically provide more detailed discussions of Ambiq’s SPOT technology, Apollo and Atomiq product families, risk factors, and management’s analysis of financial condition and results of operations. These core filings are central for understanding how Ambiq describes its ultra-low-power edge AI strategy and market exposure.
Stock Titan enhances these documents with AI-powered summaries that highlight key points from lengthy filings, helping readers quickly identify important changes in revenue trends, operating expenses, or capital structure. The platform also tracks insider-related filings such as Form 4, where available, so users can monitor equity awards and transactions involving Ambiq’s directors and executive officers.
By combining real-time updates from EDGAR with AI-generated insights, this page offers a focused view into AMBQ’s regulatory history, financial reporting practices, and governance developments, all grounded in the company’s official SEC submissions.
Ambiq Micro, Inc. reported that its General Counsel, Michele Kim Connors, received equity awards in the form of restricted stock units tied to the company’s common stock. On January 5, 2026, she was granted 23,759 units and a separate grant of 5,483 units, both reported as acquisitions at a price of $0 per share. After these grants, she beneficially owned 29,242 shares of common stock.
The first grant vests over time, with 25% of the shares vesting on January 1, 2027 and the remaining shares vesting in equal quarterly installments, assuming continued service under the company’s 2025 Equity Incentive Plan. The second grant vests with 25% of the shares on April 1, 2026, and the remaining shares vesting in equal quarterly installments on the same service condition.
Ambiq Micro, Inc. filed an initial ownership report for its General Counsel, Michele Kim Connors, stating that she currently holds no securities of the company. The filing confirms her role as an officer, specifically General Counsel, and indicates that the report is filed by a single reporting person. The form also notes that no non-derivative or derivative securities are beneficially owned, clarifying that there are no current equity holdings or reportable transactions associated with her position.
Ambiq Micro, Inc. (AMBQ) reported Q3 2025 results with net sales of
Operating expenses were
Capital and share structure updates: the company completed its IPO on July 31, 2025, issuing 4,600,000 shares and receiving
Ambiq Micro, Inc. (AMBQ) furnished quarterly results via an Item 2.02 Form 8-K. The company issued a press release reporting financial results for the quarter ended September 30, 2025, attached as Exhibit 99.1 and incorporated by reference.
The disclosure is expressly deemed “furnished” and not “filed,” which limits Section 18 liability and affects how it may be incorporated into other filings. Ambiq’s common stock trades on the NYSE under the symbol AMBQ.
Ambiq Micro (AMBQ): Kleiner Perkins-affiliated funds reported beneficial ownership of Ambiq Micro common stock as of 09/30/2025. Reported holdings include: KPCB XVI at 1,439,667 shares (7.9%); KPCB XVI Founders Fund at 49,282 shares (0.3%); KPCB XVI Associates at 1,488,949 shares (8.2%); Kleiner Perkins Select Fund at 575,867 shares (3.2%); Kleiner Perkins Select Founders Fund at 17,015 shares (0.1%); and Kleiner Perkins Select Associates at 592,882 shares (3.3%).
Each reporting person lists sole voting and dispositive power over its shares, with notes that managing members (XVI Associates or KP Select Associates, as applicable) may be deemed to have sole power to vote and dispose. The filing is a Schedule 13G, reflecting beneficial ownership positions rather than a sale or issuance.
Ambiq Micro, Inc. reported a Form 4 showing that Jeffrey G. Winzeler, the company's Chief Financial Officer and a director, was granted 52,667 restricted stock units (RSUs) on
Per the award terms,
Hanson Scott McLean, who serves as Chief Financial Officer and a director of Ambiq Micro, Inc. (AMBQ), received a grant of
Ambiq Micro, Inc. (AMBQ) reported an insider equity award: Sean Chihhsiang Chen, the company's President and COO, received 56,029 restricted stock units (RSUs) on
Ambiq Micro director and CEO Fumihide Esaka received a grant of
Ambiq Micro, Inc. reported Board-approved one-time cash bonuses awarded to four senior executives in recognition of their contributions during the company’s initial public offering and to promote retention. The specified cash awards were $328,000 to Fumihide Esaka (Chief Executive Officer), $328,000 to Scott Hanson (Chief Technology Officer), $120,000 to Jeff Winzeler (Chief Financial Officer) and $105,000 to Sean Chen (President and Chief Operating Officer). The filing also discloses that on September 29, 2025 the Board approved acceleration of one-third of Mr. Winzeler’s previously issued stock options, effective October 1, 2025. The disclosure was signed by Jeffery G. Winzeler as Chief Financial Officer.